Organogenesis Holdings Inc. (FRA:2PQ)
3.920
-0.440 (-10.09%)
At close: Jan 2, 2026
Organogenesis Holdings Employees
Organogenesis Holdings had 869 employees as of December 31, 2024. The number of employees increased by 7 or 0.81% compared to the previous year.
Employees
869
Change (1Y)
7
Growth (1Y)
0.81%
Revenue / Employee
€456,278
Profits / Employee
€9,048
Market Cap
459.34M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 869 | 7 | 0.81% |
| Dec 31, 2023 | 862 | -168 | -16.31% |
| Dec 31, 2022 | 1,030 | 80 | 8.42% |
| Dec 31, 2021 | 950 | 40 | 4.40% |
| Dec 31, 2020 | 910 | 75 | 8.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 317,562 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,995 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Organogenesis Holdings News
- 16 days ago - Organogenesis, MiMedx among decliners as Medicare to pull skin substitute LCDs - Seeking Alpha
- 18 days ago - Organogenesis Initiates BLA Submission For ReNu In Knee Arthritis - Nasdaq
- 19 days ago - Organogenesis (ORGO) Advances ReNu BLA Submission for Knee Arthritis - GuruFocus
- 19 days ago - Organogenesis starts rolling submission for ReNu allograft for knee arthritis - Seeking Alpha
- 19 days ago - Organogenesis (ORGO) Begins Rolling Submission for FDA Approval of ReNu - GuruFocus
- 19 days ago - Organogenesis Announces Initiation of Biologics License Application for ReNu - Wallstreet:Online
- 19 days ago - Organogenesis Announces Initiation of Biologics License Application for ReNu® - GlobeNewsWire
- 26 days ago - Organogenesis To File Rolling BLA For ReNu Following FDA Meeting - Nasdaq